The Journal of craniofacial surgery · 2026
Regulatory Mechanism of ERKs Pathway on Orthodontic Force Signal Transduction and Osteogenic Differentiation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Ziliang, Hu Sihui, Li Xinyi, Chen Song
Аннотация
OBJECTIVES: This study aimed to investigate the role of the extracellular signal-regulated kinases (ERKs) signaling pathway in orthodontic force-induced mechanotransduction and osteogenic differentiation, and explore its potential crosstalk with signal transducer and activator of transcription 3 (STAT3), whose regulatory mechanism remains unclear.
MATERIALS AND METHODS: In vitro, MC3T3-E1 preosteoblasts were exposed to cyclic tensile strain (2000 μstrain, 0.5 Hz, 4 h) with or without the specific ERKs inhibitor SCH772984. In vivo, a mouse orthodontic tooth movement (OTM) model was established with 4g force, and SCH772984 was locally injected into periodontal tissues. Pathway protein expression, osteogenic marker levels, tooth movement distance, and bone microarchitecture were analyzed.
RESULTS: Mechanical strain significantly activated ERKs and STAT3 phosphorylation and upregulated key osteogenic markers (Runx2, OSX, OPN, ALP) in vitro; these effects were inhibited by SCH772984 except for COL1. In vivo, orthodontic force-induced alveolar bone remodeling and OTM, with osteogenic markers predominantly elevated on the tension side. SCH772984 treatment suppressed ERKs activation and reduced tooth movement by ~40% (all P<0.05).
CONCLUSIONS: The ERKs pathway is a critical mediator of orthodontic force-induced alveolar bone remodeling and OTM, functioning partially through STAT3. These findings establish the ERKs/STAT3 axis as a promising therapeutic target for accelerating orthodontic treatment.
MATERIALS AND METHODS: In vitro, MC3T3-E1 preosteoblasts were exposed to cyclic tensile strain (2000 μstrain, 0.5 Hz, 4 h) with or without the specific ERKs inhibitor SCH772984. In vivo, a mouse orthodontic tooth movement (OTM) model was established with 4g force, and SCH772984 was locally injected into periodontal tissues. Pathway protein expression, osteogenic marker levels, tooth movement distance, and bone microarchitecture were analyzed.
RESULTS: Mechanical strain significantly activated ERKs and STAT3 phosphorylation and upregulated key osteogenic markers (Runx2, OSX, OPN, ALP) in vitro; these effects were inhibited by SCH772984 except for COL1. In vivo, orthodontic force-induced alveolar bone remodeling and OTM, with osteogenic markers predominantly elevated on the tension side. SCH772984 treatment suppressed ERKs activation and reduced tooth movement by ~40% (all P<0.05).
CONCLUSIONS: The ERKs pathway is a critical mediator of orthodontic force-induced alveolar bone remodeling and OTM, functioning partially through STAT3. These findings establish the ERKs/STAT3 axis as a promising therapeutic target for accelerating orthodontic treatment.